Anna C Martinez‐hume
Biographic Data
| ID | 3838404 |
|---|---|
| NAME | Anna C Martinez‐hume |
| GIVEN NAMES | Anna C |
| FAMILY NAME | Martinez‐hume |
| SIGNATURE | HUME A C M |
| AFFILIATIONS | Michigan State University |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 13 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 2 |
Corporate Logic in Clinical Care
As large corporations come to dominate U.S. health care, clinical medicine is increasingly market-driven and governed by business principles. We examine ways in which health insurers and health care systems are transforming the goals and means of clinical practice. Based on ethnographic research of diabetes management in a large health care system, we argue that together these organizations redefine clinical care in terms that prioritize financia…
Racialized Risk in Clinical Care
Racial/ethnic identity is contingent and arbitrary, yet it is commonly used to evaluate disease risk and treatment response. Drawing on open-ended interviews with patients and clinicians in two US clinics, we explore how racialized risk is conceptualized and how it impacts patient care and experience. We found that racial/ethnic risk was a common but poorly defined construct for both patients and clinicians, who intermingled concepts of genetics,…
Medicaid Reform, Responsiblization Policies, and the Synergism of Barriers to Low-income Health Seeking
Many recent health reforms in the United States are imbued with neoliberal responsibilization rhetoric, which encourages individual responsibility and reduced dependency on the state. This ideology is evident in waiver-modified Medicaid expansion programs which include personal responsibility requirements such as increased cost sharing and behavioral incentive programs. In this article, we explore the limits of responsibilization rhetoric in the …
“They Treat you a Different Way
Corporate Logic in Clinical Care
As large corporations come to dominate U.S. health care, clinical medicine is increasingly market-driven and governed by business principles. We examine ways in which health insurers and health care systems are transforming the goals and means of clinical practice. Based on ethnographic research of diabetes management in a large health care system, we argue that together these organizations redefine clinical care in terms that prioritize financia…
Racialized Risk in Clinical Care
Racial/ethnic identity is contingent and arbitrary, yet it is commonly used to evaluate disease risk and treatment response. Drawing on open-ended interviews with patients and clinicians in two US clinics, we explore how racialized risk is conceptualized and how it impacts patient care and experience. We found that racial/ethnic risk was a common but poorly defined construct for both patients and clinicians, who intermingled concepts of genetics,…
Medicaid Reform, Responsiblization Policies, and the Synergism of Barriers to Low-income Health Seeking
Many recent health reforms in the United States are imbued with neoliberal responsibilization rhetoric, which encourages individual responsibility and reduced dependency on the state. This ideology is evident in waiver-modified Medicaid expansion programs which include personal responsibility requirements such as increased cost sharing and behavioral incentive programs. In this article, we explore the limits of responsibilization rhetoric in the …
“They Treat you a Different Way
Corporate Logic in Clinical Care
As large corporations come to dominate U.S. health care, clinical medicine is increasingly market-driven and governed by business principles. We examine ways in which health insurers and health care systems are transforming the goals and means of clinical practice. Based on ethnographic research of diabetes management in a large health care system, we argue that together these organizations redefine clinical care in terms that prioritize financia…
Racialized Risk in Clinical Care
Racial/ethnic identity is contingent and arbitrary, yet it is commonly used to evaluate disease risk and treatment response. Drawing on open-ended interviews with patients and clinicians in two US clinics, we explore how racialized risk is conceptualized and how it impacts patient care and experience. We found that racial/ethnic risk was a common but poorly defined construct for both patients and clinicians, who intermingled concepts of genetics,…
Health care (4 works) · Business (3 works) · Economic growth (3 works) · Economics (3 works) · Medicine (3 works) · Political science (3 works) · Medicaid (2 works) · Nursing (2 works) · Anthropology (1 work) · Clinical Practice (1 work)